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Injection of human Chorionic Gonadotropin (hCG) directly into the dorsal lymph sac of Xenopus is a
commonly used protocol for induction of ovulation, but recent shortages in the stocks of commercially
available hCG as well as lack of a well tested alternative have resulted in frustrating experimental delays
in laboratories that predominantly use Xenopus in their research. Mammalian Luteinizing Hormones (LH)
share structural similarity, functional equivalency, and bind the same receptor as hCG; this suggests that
LH may serve as a good alternative to hCG for promoting ovulation in Xenopus. LH has been found to
induce maturation of Xenopus oocytes in vitro, but whether it can be used to induce ovulation in vivo has
not been examined. Here we compared the ability of four mammalian LH proteins, bovine (bLH), human
(hLH), ovine (oLH), porcine (pLH), to induce ovulation in Xenopus when injected into the dorsal lymph
sac of sexually mature females. We ﬁnd that both ovine and human LH, but not bovine or porcine, are
good substitutes for hCG for induction of ovulation in WT and J strain Xenopus laevis and Xenopus tro-
picalis.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Induction of ovulation in Xenopus by injection of human
Chorionic Gonadotropin (hCG) directly into the dorsal lymph sac is
a well established protocol (Sive et al., 2000). This protocol has its
roots in some of the earliest experimental work done in Xenopus
more than eight decades ago. In the early 1930s, while studying
the role of pituitary hormones in Xenopus laevis pigmentation,
Hogben et al. (1931) described that injection of extracts from the
anterior pituitary of an ox could induce ovulation in X. laevis at any
time of the year and that hypophysectomy resulted in striking
ovarian regression. This suggested that X. laevis may serve as a
good system for detection of gonadotropic activity and directly led
to the development of the Xenopus test for early pregnancy in
which induction of ovulation was scored following injection of
urine collected from human females (Elkan, 1938, 1946). Further
work in biochemistry led to the puriﬁcation and identiﬁcation of
hCG as the active component in pregnant urine responsible for
induction of ovulation in the frog and eventually led to commer-
cial availability of puriﬁed hCG (Practice Committee of AmericanInc. This is an open access article u
mhorb@mbl.edu (M.E. Horb).Society for Reproductive Medicine, Birmingham, Alabama, 2008).
The increased access to the puriﬁed hormone together with de-
velopment of protocols for maintenance and breeding of captive X.
laevis allowed for its establishment as an experimental model
system capable of providing large quantities of equivalent material
all year round for use in biochemistry, embryology, and develop-
ment biology (Gurdon and Hopwood, 2000).
Although Chorionic Gonadotropin (CG) is only found in primate
and equine genomes, it is structurally similar to Luteinizing Hor-
mone (LH), which is found in all vertebrates (Choi and Smitz,
2014). Both CG and LH are heterodimer glycoproteins composed of
two subunits, α and β (Choi and Smitz, 2014); the α subunit is
identical for both, while the β subunits are encoded by distinct
genes (Boorstein et al., 1982; Naylor et al., 1983). In vivo, each
hormone exists as a cocktail of distinct isoforms resulting from
extensive post-translational glycosylation, sialylation and sulpho-
nation (Choi and Smitz, 2014). The differences in the extent of
post-translation modiﬁcation between the two hormones are
thought to account for the variability in their perdurance and for
the fact that despite both activating the same Luteinizing Hor-
mone/choriogonadotropin receptor (LHCGR), each promotes a
distinct downstream signaling response (Choi and Smitz, 2014).
In recent years, the intermittent shortages of commercially
available hCG have led to sporadic and frustrating interference
with experimental work relying on induction of Xenopusnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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hormones, previous data using Xenopus oocytes and other anuran
species suggest that LH derived frommammalian sources is a good
candidate as an alternative to hCG in induction of Xenopus ovu-
lation. In amphibians, the ﬁnal steps of oocyte maturation occur
shortly before ovulation and are characterized by meiotic division
and the resulting breakdown of nuclear envelope and extrusion of
the ﬁrst polar body (Thornton, 1971). Ovine LH (oLH) was de-
monstrated as highly speciﬁc in promoting oocyte meiotic ma-
turation in isolated X. laevis ovaries (Licht et al., 1976). Further-
more, oLH effectively induced ovulation in ovaries isolated from
another anuran, Rana pipiens and also stimulated high levels of
progesterone production in ovarian fragments from Rana ca-
tesbeiana (Bergers and Li, 1960; Licht et al., 1976; Ogawa et al.,
2011).
We decided to investigate whether injection of mammalian LH
proteins into the dorsal lymph sac of X. laevis and X. tropicalis
would be sufﬁcient to promote ovulation and therefore could be
used as an alternative to hCG. We tested the efﬁciency of LH
proteins derived from four distinct mammalian sources: bovine
(bLH), human (hLH), ovine (oLH) and porcine (pLH) to induce egg
laying in Xenopus by measuring the number of eggs laid. With the
recent completion of the X. laevis genome using the inbred J strain
(Session et al., 2016) we compared the responses in both out-
crossed wild type (WT) and inbred J strain X. laevis. We found that
oLH and hLH are as efﬁcient at inducing spawning as hCG, whereas
bLH and pLH were less effective at inducing ovulation. In X. tro-
picalis, we found that oLH is as efﬁcient as hCG in inducing ovu-
lation, but that the batch size produced by oLH injected females is
always smaller. Nonetheless, the oLH injected X. tropicalis females
still produce eggs in numbers sufﬁcient for experimental work.
Our results demonstrate that oLH and hLH can be used as a sub-
stitute for hCG in Xenopus to promote ovulation.2. Materials and methods
2.1. Husbandry
All animals were housed and handled in the National Xenopus
Resource in accordance with animal care protocol 15-02B ap-
proved by the Marine Biology Laboratory IACUC.
2.2. Spawning
Spawning was induced in sexually mature X. laevis wild type
and J strain females by ﬁrst priming with an injection of 50 IU
(WT) or 35 IU (J strain) PMSG, respectively, followed 2–4 days later
by the injection of hCG, recombinant hCG, bovine LH, human LH,
ovine LH, or porcine LH. Two females per tank were kept at room
temperature and were allowed to spawn for 22 h. The next day
each female was squeezed 2–3 times to help induce spawning.
After 22 h, all eggs were collected and the volume of eggs with
jelly coats still on was measured and used to estimate the total
number of eggs. Eggs were collected into falcon tubes and allowed
to settle for at least 5 min before volume measurements were
made.
A similar approach was used for X. tropicalis where females
were primed with 10 IU of hCG or 15 IU of PMSG, then boosted 1–2
days later with hCG, rhCG, or oLH. Following boosting, females
were kept at 3 per tank at 25–27 °C and allowed to lay eggs for 8 h,
after which the eggs were collected, their volumes measured and
the average number of eggs laid per female was calculated. While
laying, each female was squeezed 1–2 times.
Females that did not produce any eggs during the squeezing
nor during frequent observations throughout the experiment aswell as the ones that did not show a pronounced engorgement of
the labia and as such were not responding to the hormone were
considered as not having laid any eggs throughout the experiment.
2.3. Egg counting
To convert volume of eggs laid to total number of eggs we ﬁrst
established the average number of eggs per mL laid by J strain and
WT X. laevis and X. tropicalis as follows. 5 mL of eggs were collected
in a 50 mL falcon tube from three individual females and, after de-
jellying, the total number of eggs was counted and used to calculate
the average number of eggs/mL. This gave 150 eggs/mL for WT X.
laevis, 200 eggs/mL for J strain, and 344 eggs/mL for X. tropicalis.
2.4. Hormones
Highly puriﬁed bovine, human, ovine and porcine Luteinizing
Hormones as well as rhCG and hCG were ordered from the Na-
tional Hormone and Peptide Program (www.humc.edu/hor
mones). PMSG was procured from Fisher Scientiﬁc (Catalog #
50893505).
2.5. Statistical analysis
Statistical analysis was performed in MATLAB. The following
code was used.
hcg¼[2775 3100 3900 3800 500 6075 975 8250];
lh¼[4900 3800 2500 3300 3600 9200 400 2200 2700 7200
4050];
[h, p, ks2stat]¼kstest2(hcg, lh).3. Results
3.1. Efﬁcient induction of ovulation in Xenopus with ovine Luteiniz-
ing Hormone
To determine if oLH can be used as a substitute for hCG, we
compared the ability of each hormone to induce ovulation in vivo
in X. laevis in both inbred J strain and outcrossed female X. laevis.
Initially, we used oocyte positive females (i.e. those with a de-
monstrated prior history of oocyte production) that were at least
18 months old. As J strain frogs are smaller than traditional out-
crossed frogs we tested various doses of each hormone. Female
frogs were initially primed with PMSG 2–4 days prior to injection
of hCG or LH and were not fed during this time. The frogs were
then injected with different doses of hormone and allowed to lay
eggs for 22 h, after which the eggs were collected and the volume
measured; during egg laying, the frogs were manually squeezed
three times before collection. At 350 IU, 400 IU, or 450 IU of hCG
female J strain frogs produced approximately 2400 eggs (Fig. 1A).
At the highest dose of 500 IU of hCG J strain female frogs produced
an average of 3294 eggs (Fig. 1A). In comparison, J strain females
also responded well to oLH. At the lowest dose (100 μg) the fe-
males laid fewer eggs than hCG, averaging 1880 eggs (Fig. 1A). The
number of eggs laid increased with higher doses of oLH; at 150 μg
they produced 2888 eggs, and females boosted with 200 μg oLH
produced 3738 eggs (Fig. 1A). Although all three doses were suf-
ﬁcient to induce egg laying, the highest dose of oLH was the most
efﬁcient and consistent. All eggs laid by J strain females were of
good quality and fertilized efﬁciently in vitro with J strain male
sperm and developed normally (data not shown). We have been
using oLH in place of hCG for over six months now and have not
seen a large difference in quality of eggs produced and fertilized,
nor has this affected the maturation of resulting tadpoles to
froglets and adults.
Fig. 1. Ovine Luteinizing Hormone efﬁciently induces spawning in both J strain and WT X. laevis, independent of egg laying history. (A) J strain oþ , (B) WT oþ , (C) J strain
virgin, and (D) WT virgin X. laevis females were boosted with either hCG or oLH. The height of each bar indicates the average number of eggs laid per female with the error
bars showing the standard error of the mean. The ratios within each bar represent the corresponding number of females that laid eggs per number of females boosted. Only
females that laid were included in the calculations of average number of eggs laid and the standard error of the mean. The amount and type of hormone used are indicated
on the bottom of each graph.
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the sequencing of X. laevis genome (Session et al., 2016); since
many laboratories working with X. laevis predominantly use out-
crossed wild type (WT) frogs purchased from commercial vendors
we examined whether oLH was as effective at inducing ovulation
in WT X. laevis. At 500 IU and 550 IU of hCG the females produced
an average of 5940 and 4470 eggs (Fig. 1B); lower doses of hCG
were not effective at inducing egg laying in WT X. laevis. We ob-
served a comparable spawning efﬁciency at the highest doses of
oLH used. At 150 μg oLH the boosted animals produced an average
of only 1500 eggs, with only 66% of injected frogs laying eggs
(Fig. 1B). At higher doses we found more consistent numbers of
WT frogs laying eggs; at 200 μg they produced 3994 eggs, at
250 μg they produced 2644 eggs, and at the highest dose of
300 μg they produced 4700 eggs (Fig. 1B). Thus, oLH is able to
induce spawning in oocyte positive outcrossed females at efﬁ-
ciencies comparable to those obtained with hCG, but required
slightly higher doses as compared to J strain females. This is
consistent with the fact that WT oþ frogs are approximately 60%
larger than J strain frogs (Table 1).
Both hCG and oLH efﬁciently induce ovulation at the highest
dose tried. Combining the results from J strain and WT oocyte
positive females, 14 females of the 15 injected with hCG and 21 ofthe 22 injected with oLH ovulated. In both conditions, a single WT
female did not spawn. High rates of ovulation do not necessarily
mean that both hormones are able to induce production of equally
high numbers of eggs. To test the equivalency of the two hor-
mones in relation to the number of eggs produced we performed a
two-sample nonparametric Kolmogorov-Smirnov test (Massey,
1951). In our experimental design two females were included per
tank and the number of eggs laid was calculated as an average and
thus to provide sufﬁcient power for this statistical analysis we
combined the J strain and WT data. The tanks that included the
WT females that did not lay were also included in the calculation.
We were not able to reject the null hypothesis that both hormones
would produce equivalent egg number distributions and the
asymptotic P-value (considered accurate for our sample sizes) is
0.9183. This supports the conclusion that at the highest doses
tested not only are hCG and oLH essentially identical in their ef-
ﬁciency at inducing ovulation but they also produce equivalent
numbers of eggs.
To assess whether prior spawning history had any inﬂuence on
the ability of X. laevis females to respond to oLH, we compared the
efﬁciencies of hCG and oLH to promote egg laying in virgin J strain
and WT females. In virgin J strain females boosted with hCG we
found similar results with all three doses tested. At 400 and 450 IU
Table 1
Weight of X. laevis and X. tropicalis and associated hormone dose.
Figure panel Strain Breeding history Experimental condition Individual mass of females used (g) Mean mass
(g)
Hormone dose per gram
mass
1A J Oþ 350 IU hCG 58.2, 63.9, 49.3, 57.0 57.1 6.13 IU
400 IU hCG 76.9, 66.1, 79.7, 83.7 76.6 5.22 IU
450 IU hCG 89.7, 72.3, 53.2, 52.9 67.03 6.71 IU
500 IU hCG 59.0, 80.0, 68.0, 70.0, 60.0, 80.0, 55.7, 91.6, 78.3 71.4 7.00 IU
100 μg oLH 58.9, 74.6, 72.2, 66.8, 42.5, 52.2, 42.4, 74.0, 101.0, 84.5,
105.0, 96.0
72.53 1.38 μg
150 μg oLH 66.0, 55.2, 56.2, 69.5, 90.0, 113.5, 94.4, 107.0, 86.0, 95.0,
79.3, 99.2
84.28 1.78 μg
200 μg oLH 87.0, 72.0, 85.0, 69.0, 92.1, 75.8, 57.8, 74.3, 95.0, 93.5,
97.0, 106.5, 80.1, 70.2, 74.0, 89.0
82.39 2.43 μg
1B WT Oþ 500 IU hCG 79.4, 98.3, 88.5, 75.8, 82.5, 152.4 96.15 5.20 IU
550 IU hCG 88.2, 77.6, 63.3, 174.5, 171.2, 112.9 114.62 4.80 IU
150 μg oLH 97.3, 135.8, 130.4, 93.9, 109.7, 154.3 120.23 1.25 μg
200 μg oLH 110.4, 139.4, 99.3, 140.4, 171.8, 203.1, 164.5, 259.3 161.03 1.24 μg
250 μg oLH 126.0, 85.0, 88.7, 87.9, 129.2, 144.4, 145.0, 170.4 122.08 2.05 μg
300 μg oLH 121.9, 87.8, 137.6, 138.5, 124.1, 195.5 134.23 2.24 μg
1C J Virgin 400 IU hCG 52.2, 43.3, 62.0, 64.4, 55.5, 34.2 51.93 7.70 IU
450 IU hCG 49.7, 52.2, 48.7, 53.4, 60.9, 34.1 49.83 9.03 IU
500 IU hCG 61.4, 72.1, 64.4, 53.4, 49.7, 41.1 57.07 8.76 IU
100 μg oLH 75.3, 59.5, 49.6, 60.1, 39.6, 39.8 53.98 1.85 μg
150 μg oLH 61.5, 74.2, 50.9, 71.1, 33.3, 69.8 60.13 2.49 μg
200 μg oLH 56.6, 74.5, 55.5, 72.6, 65.4, 48.3 62.15 3.22 μg
1D WT Virgin 450 IU hCG 73.0, 86.1, 88.3, 98.6, 96.4, 97.7 90.02 5.00 IU
500 IU hCG 112.8, 131.5, 104.1, 137.8, 73.4, 123.9 113.92 4.38 IU
550 IU hCG 108.2, 85.4, 97.4, 114.5, 52.1, 87.8 90.9 6.05 IU
150 μg oLH 105.9, 105.4, 108.1, 115.6, 96.4, 126.4 109.63 1.37 μg
200 μg oLH 143.9, 99.8, 110.5, 87.2, 82.4, 81.3, 146.8, 118.5, 82.8, 93.0,
104.3
104.58 1.91 μg
250 μg oLH 108.5, 135.1, 102.5, 113.8, 104.0, 120.0, 76.5, 128.8, 61.6,
92.5, 87.0, 91.6
101.81 2.46 μg
2A J Oþ 100 μg bLH 55.2, 76.5, 63.4, 82.1, 87.5, 32.9 66.27 1.51 μg
150 μg bLH 61.3, 41.3, 82.5, 29.9, 47.4, 88.1 58.43 2.57 μg
200 μg bLH 95.9, 87.7, 47.5, 49.6, 53.0, 77.6 68.54 2.92 μg
100 μg hLH 67.4, 55.1, 57.0, 60.1, 99.2, 77.3 69.35 1.44 μg
150 μg hLH 58.4, 69.7, 93.6, 98.5, 69.1, 53.4 73.78 2.03 μg
200 μg hLH 49.6, 100.5, 97.0, 67.0, 47.9, 48.2 68.37 2.93 μg
100 μg pLH 44.4, 68.7, 65.2, 92.5 67.7 1.48 μg
150 μg pLH 48.2, 91.6, 57.4, 74.2, 70.8, 61.9 67.35 2.23 μg
200 μg pLH 62.6, 107.9, 64.8, 87.7, 61.0, 85.6 78.28 2.56 μg
2B WT Oþ 200 μg bLH 164.3, 124.4, 154.1, 107.0, 164.4, 170.8 147.5 1.36 μg
250 μg bLH 124.0, 73.8, 85.2, 157.0, 93.6, 200.3 122.32 2.04 μg
200 μg hLH 129.8, 127.3, 85.0, 132.0, 153.3, 215.2 140.43 1.42 μg
250 μg hLH 157.6, 125.3, 80.3, 168.7, 106.6, 151.3 131.63 1.90 μg
200 μg pLH 139.4, 192.7, 165.9, 205.8, 86.2, 112.4 150.4 1.33 μg
250 μg pLH 171.6, 184.5, 116.5, 166.1, 170.4, 178.9 164.67 1.52 μg
3 TROP Oþ 10 IU hCG/100 IU hCG 18.1, 23.5, 16.9, 19.9, 17.0, 18.9 19.05 5.25 IU
10 IU hCG/150 IU hCG 15.1, 23.2, 17.4, 23.2, 17.2, 13.6 18.28 8.20 IU
10 IU hCG/100 IU rhCG 16.8, 23.2, 17.9, 14.5, 16.5, 12.6 17 5.88 IU
10 IU hCG/150 IU rhCG 15.6, 20.8, 23.4, 19.7, 13.2, 14.2 17.82 8.42 IU
10 IU hCG/25 μg oLH 16.0, 14.4, 17.7, 17.1, 11.4, 16.3 15.48 1.62 μg
10 IU hCG/50 μg oLH 20.3, 16.7, 17.1, 17.4, 16.0, 18.1, 15.9, 20.7, 15.9, 19.2 17.73 2.82 μg
10 IU hCG/75 μg oLH 14.3, 14.5, 13.6, 14.7, 17.7, 19.8, 15.8, 12.1 15.31 4.90 μg
10 IU hCG/100 μg oLH 17.9, 13.6, 14.5, 18.7, 11.6, 16.4, 15.9 15.51 6.45 μg
15 IU PMSG/100 IU hCG 19.0, 16.6, 21.6, 17.9, 13.0, 15.4 17.25 6.80 IU
15 IU PMSG/150 IU hCG 14.0, 21.1, 21.5, 17.4, 16.8, 15.5 17.72 8.47 IU
15 IU PMSG/100 IU rhCG 17.8, 24.6, 20.0, 16.3, 16.7, 18.5, 18.6 18.93 5.28 IU
15 IU PMSG/150 IU rhCG 13.9, 18.8, 16.5, 16.1, 15.2, 14.2, 16.3 15.86 9.46 IU
15 IU PMSG/25 μg oLH 15.7, 18.0, 11.6, 17.9, 14.3, 16.9, 18.1, 15.5 16 1.56 μg
15 IU PMSG/50 μg oLH 19.2, 15.5, 16.0, 17.1, 15.7, 10.0, 13.8, 19.6, 16.7, 17.2 16.08 3.11 μg
15 IU PMSG/75 μg oLH 13.2, 17.3, 14.2, 15.7, 19.4, 15.1, 14.9, 11.1, 12.7 14.84 5.05 μg
15 IU PMSG/100 μg oLH 15.4, 20.2, 15.4, 17.7, 13.3, 17.3, 17.7, 19.3, 20.6 17.43 5.74 μg
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spectively, while ﬁve out of six females injected with 500 IU
produced an average of 4480 eggs (Fig. 1C). Boosting virgin J strain
females with oLH was also effective with all virgin frogs tested
laying eggs; 3300 eggs with 100 μg, 3267 with 150 μg, and 3600
with 200 μg (Fig. 1C). Conversely, in WT virgin females we foundthat oLH was less effective than hCG at inducing egg laying; most
hCG injected virgin females laid eggs, whereas the results were
more variable with oLH. hCG injected virgin females laid an
average of 2800 eggs when injected with 450 IU (3/6), 2775 with
500 IU (5/6), and 1950 with 550 IU (5/6) (Fig. 1D). oLH injected
virgin WT frogs laid fewer eggs than with hCG, even at the highest
M. Wlizla et al. / Developmental Biology 426 (2017) 442–448446dose of oLH. At 150 μg four of six females laid 975 eggs, 1294 eggs
were laid by eight of eleven females injected with 200 μg, and at
250 μg the females produced 1714 eggs (Fig. 1D). Thus, in virgin
female frogs hCG was more effective at inducing egg laying and
produced a greater number of eggs than oLH.
Based on our results we found that oLH is an effective sub-
stitute for hCG, and the most effective dose correlates with the size
of the female frog. Overall, we found J strain frogs weigh ap-
proximately 60% less than WT frogs, with J strain virgin frogs
averaging 55.8 g and J strain oþ frogs weighing 76.2 g, whereas
WT virgin frogs were on average 102.1 g and WT oþ frogs
weighing 126.5 g (Table 1). To determine the most effective dose
we calculated the amount of oLH used (μg) per gram body weight
that resulted in the largest number of eggs and highest percentage
of injected females laying. In the oLH injections the hormone
concentrations tested ranged from 1.38 μg to 3.22 μg per gram of
average body mass in J strain frogs, and from 1.25 μg to 2.46 μg
per gram of body mass in WT frogs (Table 1). Based on these re-
sults we estimate that 2.5 μg/g of oLH is the most effective dose;
on average this amounts to 150–200 μg for J strain frogs and 250–
300 μg for WT frogs.
3.2. Human but not bovine nor porcine Luteinizing Hormones pro-
mote efﬁcient egg laying in X. laevis
The amino acid sequences of Luteinizing Hormone in various
species are highly similar, but contain different posttranslational
modiﬁcations. We decided to test whether using LuteinizingFig. 2. Efﬁciency of spawning in J strain and WT oþ females boosted with either bLH, hL
bLH, hLH, or pLH. The height of each bar indicates the average number of eggs laid per fe
or above each bar represent the corresponding number of females that laid eggs per num
average number of eggs laid and the standard error of the mean. The amount and typeHormone derived from three alternate mammalian sources, bo-
vine (bLH), human (hLH), and porcine (pLH), would demonstrate a
similar ability to promote egg laying in X. laevis as oLH and hCG
did. For consistency, we tested the effectiveness of other LH pre-
parations only in oþ J strain and WT frogs and found comparable
results in both strains. In J strain females, bLH was an inconsistent
inducer of egg laying, with only 300 eggs produced by two of six
female frogs injected with 100 μg, 1950 eggs laid by four of six
injected with 150 μg, and 3500 eggs laid by only two of six in-
jected with 250 μg (Fig. 2A). hLH was considerably more effective
at inducing spawning with 100 μg producing an average of 3200
eggs, 150 μg producing 4500 eggs, and 200 μg producing 3456
eggs (Fig. 2A). Boosting with pLH resulted in poor and inconsistent
spawning with none of the four females injected with 100 μg
producing any eggs, only two of six injected with 150 μg produ-
cing an average of 1400 eggs, and two of six injected with 200 μg
producing an average of 500 eggs (Fig. 2A).
WT females showed somewhat similar responses to these three
mammalian hormones. They responded more consistently to bLH
but produced small egg batches. Four of six injected with 200 μg
of bLH produced an average of 1706 eggs, and all six injected with
250 μg produced 2050 eggs on average (Fig. 2B). hLH was more
efﬁcient at inducing spawning. All six females injected with
200 μg laid an average of 3756 eggs, and all six frogs injected with
250 μg laying 6825 eggs on average (Fig. 2B). None of the six fe-
males injected with 200 μg of pLH nor the six injected with 250 μg
of it laid any eggs (Fig. 2B). When accounting for the body mass of
the females injected, on average all the three hormones wereH, or pLH. (A) J strain oþ , and (B) WT oþ X. laevis females were boosted with either
male with the error bars showing the standard error of the mean. The ratios within
ber of females boosted. Only females that laid were included in the calculations of
of hormone used are indicated beneath the bars.
Fig. 3. Spawning efﬁciency in X. tropicalis females ﬁrst primed with either hCG or PMSG and then boosted with hCG, rhCG, or oLH. X. tropicalis females were primed with
either 10 IU of hCG (green bars) or 15 IU of PMSG (blue bars). The height of each bar indicates the average number of eggs laid per female with the error bars showing the
standard error of the mean. The ratios within each bar represent the number of females that laid eggs per number of females boosted. Only females that laid were included in
the calculations of average number of eggs laid and the standard error of the mean. The amount and type of hormone used are indicated on the bottom of the graph.
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(Table 1). In conclusion, only human LH, and not bLH nor pLH, was
as effective as ovine LH at inducing egg laying in X. laevis.
3.3. Boosting X. tropicalis females with oLH promotes egg laying
X. tropicalis is the other species within the Xenopus genus that
is commonly used as a developmental biology model system. As a
ﬁnal test, we decided to investigate whether, just as in X. laevis,
boosting with oLH could be used to promote egg laying in X. tro-
picalis. Furthermore, we also investigated whether egg laying re-
sponse to the boosting hormone tested, was differentially affected
by prior priming of the females with either 10 IU of hCG or 15 IU of
PMSG.
Of the individuals primed with hCG and then boosted with 100
IU of hCG four in six produced an average of 731 eggs, and ﬁve in
six boosted with 150 IU produced an average of 1651 eggs (Fig. 3).
Surprisingly, the females gave a mixed response to recombinant
hCG (rhCG). Five of the six females boosted with 100 IU rhCG
produced an average of 1174 eggs but only three of the six boosted
with 150 IU laid 573 eggs (Fig. 3). The females responded more
consistently to oLH than they did to rhCG, though the average
clutch size did not reach the amount resulting from boosting with
150 IU of hCG. Five of six females boosted with 25 μg of oLH
produced an average of 860 eggs, nine of ten boosted with 50 μg
produced 898, seven of eight boosted with 75 μg produced 1057,
and six of seven boosted with 100 μg produced 803 (Fig. 3).
The main observable difference between priming with 10 IU of
hCG and 15 IU of PMSG was the much better response to boosting
with rhCG in the PMSG primed females. Among those, four of six
boosted with 100 IU of hCG produced an average of 989 eggs, and
four of six boosted with 150 IU laid an average of 1720 eggs (Fig. 3).
Among the females boosted with rhCG four of seven boosted with
100 IU produced an average of 1548 eggs and ﬁve of seven boosted
with 150 IU produced an average of 1686 eggs (Fig. 3). PMSG
priming did not seem to have as much effect on increasing the
clutch sizes of animals boosted with oLH; nonetheless, these fe-
males still laid eggs in numbers sufﬁcient for experimental work.
Two of eight individuals boosted with 25 μg produced an average of
688 eggs, all ten boosted with 50 μg produced 894, all nine boosted
with 75 μg produced 1338, and eight of the nine boosted with
100 μg produced 860 (Fig. 3). In the X. tropicalis oLH trials we tested
a range of concentrations from 1.56 μg to 6.45 μg/g body mass, with
approximately 5 μg per gram providing the largest batch size (Ta-
ble 1). In conclusion, as in X. laevis, boosting with oLH promotes
efﬁcient egg laying in X. tropicalis at clutch sizes sufﬁciently large for
experimental work. Furthermore, priming with 15 IU of PMSG
produces essentially similar response to the boosting hormone as
priming with 10 IU of hCG.4. Discussion
In this paper, we describe a convenient and efﬁcient method for
induction of ovulation in Xenopus that can be used in lieu of the
established protocol relying on injection of hCG into the dorsal
lymph sac (Sive et al., 2000). The only difference is substitution of
hCG with oLH, with the overall technique still based on dorsal
lymph sac injection and thus not requiring any additional training.
Our results clearly demonstrate that in both WT and J strain X.
laevis females, oLH is capable of inducing ovulation as efﬁciently as
hCG independent of prior breeding history. The numbers of eggs
laid are generally comparable between the two hormones with the
only potential exception being that WT virgin females do not ap-
pear to lay as many eggs when injected with oLH. It is possible that
a higher amount if oLH may increase the number of eggs laid, but
in general we found that approximately 2.5 μg/g of oLH was suf-
ﬁcient to replicate results produced by hCG.
oLH is also effective at inducing ovulation in X. tropicalis. We
tested a range of concentrations from approximately 1.5 μg to
6.5 μg per gram of body mass. We observed that the females re-
spond best to 5 μg of oLH per gram of body mass. At this con-
centration they spawned at frequencies surpassing those of fe-
males injected with hCG (94% vs 75%), however oLH boosted fe-
males never produced as many eggs as those boosted with hCG. In
this case, increasing the amount of oLH may not be a viable ap-
proach for increasing the number of eggs laid, as in our experi-
ments higher concentrations actually decreased the average
number of eggs laid. Finally, we observed that X. tropicalis primed
with either hCG or PMSG responded equally well to boosting with
oLH.
In X. laevis we also tested responses to three additional Lutei-
nizing Hormones, bovine, human and porcine LH. Only hLH con-
sistently produced results, which suggests it may also serve as a
good substitute for boosting with hCG. Although we were dis-
appointed that not all of the mammalian hormones tested pro-
duced a similarly high ovulation response, this observation is not
at all surprising. A previous comparison of LH preparations from
nine species of eutherian mammals demonstrated a broad range in
their ability to promote X. laevis oocyte maturation in vitro, with
the ovine derived LH being the most effective (Licht and Papkoff,
1976).
In conclusion, we found that boosting Xenopus with oLH can be
used in place of hCG to induce ovulation, at a dose of approxi-
mately 2.5 μg/g oLH in X. laevis and twice that concentration in X.
tropicalis. Furthermore, as a practical comparison, the oLH avail-
able from the National Hormone and Peptide Program is priced at
$150.00 per 10 mg, which ends up costing $3.00 per boosting in-
jection per WT X. laevis female. The hCG available from Sigma-
Aldrich (Catalog # CG10) when bought in bulk of 10 vials each
containing 10,000 IU is priced at $956.00 which brings the cost of
M. Wlizla et al. / Developmental Biology 426 (2017) 442–448448each boosting injection to $4.78. Thus, the use of oLH will not only
aid in avoiding any disruption in experimental work resulting from
shortages in commercially available hCG but might also aid in
lowering the overall experimental costs.Acknowledgements
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